Log In
Print
BCIQ
Print
Print this Print this
 

darapladib (SB-480848)

Also known as: Lp-PLA2 inhibitor (480848)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionSmall molecule inhibitor of vascular inflammation mediator lipoprotein-associated phospholipase A2 (PLA2G7; PAFAH; Lp-PLA2)
Molecular Target Lipoprotein-associated phospholipase A2 (PLA2G7) (PAFAH) (Lp-PLA2)
Mechanism of ActionLipoprotein-associated phopholipase A2 (Lp-PLA2) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today